Table 1.
Initial proposala | First round proposalb | Agreement after first roundb | Second round proposalb | Final agreementa | |
---|---|---|---|---|---|
Number of drugsc | 111 | 98 | 93 | 56 | 106 |
Continuous infusion | 46 | 40 | 35 | 24 | 39 |
Intermittent infusion | 71 | 62 | 62 | 32 | 71 |
Number of concentrations | 221 | 205 | 82 | 81 | 183 |
Continuous infusion | 109 | 102 | 24 | 41 (one new strength proposal) | 67 |
Intermittent infusion | 112 | 103 | 58 | 40 (three new strengths proposals) | 116 |
Agreement for a definite concentration was achieved after the first round if it was selected by at least 70% of the panel members
Final agreement was achieved after the second round when concentrations with 40–69% votes were discussed
aReady-to-use drugs included (13 drugs; 16 different strengths)
bReady-to-use drugs excluded
cSome of the drugs are included in both continuous and intermittent infusions